erstaunlich warum die so hohe Verluste haben Kicky 20.09.02 01:03
wo sie doch eine Vereinbarung mit Südafrika und China und wem sonst noch haben für ihren längst bekannten Urintest,(der meines Wissens durchaus nicht der einzige Schelltest ist
http://www.gaifar.com/zdf-online-interview.htm ),und eigentlich im Geld schwimmen müssten,da mussten sie 2,2 Millionen Aktien für 237000$ an TUI verkaufen weil offenbar ihr Cashflow zu mager wurde und diese TUI haben gestern ihr Filing bei der SEC veröffentlicht ,dasss sie verkaufen... und immer wieder taucht Subway.com auf und preist die alten Kamellen in neuer Kleidung höchst erfolgreich zum Erstaunen der Zocker in USA an,die sich fragen wer denn hier wie blöd kauft.
aus einem bekannten Bord:
CALY Receives $237K from Stock Sale/Equity Agreement
The company that bought 2.2 million shares
Filed yesterday to sell same. Today we get the pump from Subway ( 6 different "pumps)And TIL is dumping. Within a few there will be more bogus stories from the company followed by another filing to sell shares
No legitimate institution
Buys penny stocks. All you have are offshore, unregulated scumbags playing this stock.In the past 2 months over 7 million shares have been filed to sell from these scumbag "investors".
which pump and dump "crew" made their appearance today?
Ende des Zitats
naja und der letzte Beitrag bei Bloomberg zu Caly sprach von der Gefahr der Insolvenz
Alameda, California, April 17 (Bloomberg) -- Calypte Biomedical Corp. said it is firing as many as 40 employees, or half of the medical test maker's workforce, and may soon file for bankruptcy.
The Alameda, California-based company is best known for its urine-based HIV tests, which are mainly used by insurance companies to screen potential customers against the AIDS virus. Shares soared in August 2000 when the company said it won approval to sell the test in China.
Calypte had difficulty marketing the tests though, and its products had sales of only about $7 million last year. The company has been losing more money than it has been able to bring in for the last 12 months, even amidst increasing sales, and has struggled to find investors, officials said.
``We are at a point now where we will either get acquired pretty quickly, or we'll close it up,'' said Richard Brounstein, chief financial officer for Calypte. ``Sales have grown, the company doubled last year. But new money always wanted to invest in moving the business forward.''
aber ihr liebt es ja heiss!